Z

Review of Evolving Treatment Landscape for Chronic GVHD: Targeting BTK, JAK, and ROCK2 Inhibitors

By Zachariah DeFilipp 3 Videos
312 views
May 28, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
08:02
ASH 2022 Conference Coverage

ASH 2022 Results From Phase III BMT CTN 1703: Post-Transplant Cyclop…

Feat. S. Holtan
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
37:04
Nebraska Oncology Society

Survivorship After Transplant and CAR-T for Hematologic Malignancies

Feat. N. Ahmed
17:23
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

New Approaches to Preventing and Treating GVHD

Feat. N. Hossain
12:09
Pooja Khandelwal

Treating Fibrosis and Inflammation in GvHD

37:22
MyCancerHaven

Experts Discuss the Basics of GVHD

Feat. R. Vij, I. Pusic
24:04
Yale Cancer Center

Updates on Allogeneic Stem Cell Transplant

Feat. L. Bachegowda
10:54
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Results From AGAVE-201 - Axatilimab at 3 Di…

Feat. D. Wolff
17:18
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Approaches to Preventing and Treating GVHD in 2024

Feat. N. Hossain
31:16
Indy Hematology Review

Hematopoietic Stem Cell Transplantation: State of the Art in 2023

Feat. R. Childs
27:21
UChicago Medicine

Updates in Transplantation and GVHD From Recent Meetings

Feat. M. Nawas
14:22
Pooja Khandelwal

TANDEM 2023 Single-Center Randomized Double Blinded Placebo-Controll…

14:10
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Relapse Incidence Post Unrelated alloSCT Wi…

Feat. A. Nagler
11:41
i3 Health

New Opportunities for Improved Patient Outcomes in GVHD

Feat. S. Holtan, C. Kitko
16:11
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Familial Predisposition to AML: Prevalence & Implicati…

Feat. L. Godley
14:54
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Clonal Hematopoiesis Is Common in Unrelated…

Feat. J. Schetelig
08:49
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophy…

Feat. S. Holtan